Hyperfine (HYPR): Utang-utang marang kapitalisasi buku

Tandha merek Hyperfine Corp (HYPR)

Hyperfine, Inc. (HYPR) is scaling the deployment of mobile MRI scanners through alliances with AI developers. The business relies on stable demand within the healthcare sector, although implementation rates depend on US government budgets, and the indicator stands at 0.35. This price chart clearly illustrates the stock's dynamics. Equipment is delivered via air freight, while cloud-based data exchange significantly optimizes patient examination costs.

HYPR Rasio utang marang nilai buku Hyperfine, Inc. (04.07.2022 - 27.10.2026)

Ringkesan rincian data analitis Hyperfine Inc (HYPR)

- rega lan prakiraan konsensus rega:
Rega saham Hyperfine, Inc.|HYPR - Prakiraan konsensus analis
- data kapitalisasi pasar:
Kapitalisasi pasar Hyperfine Medical|HYPR - Nilai Perusahaan Nalika Diakuisisi Penuh
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Hyperfine|HYPR - Kapitalisasi Akuntansi|Rasio Nilai Pasar marang Nilai Buku hyperfine.io|HYPR - Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Hyperfine, Inc.|HYPR - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Hyperfine Corp|HYPR - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Hyperfine Medical
Analisis fundamental perusahaan:Hyperfine, Inc.
Produk merek Hyperfine Medical

To objectively assess the issuer's financial stability, it is critical to track the total liabilities-to-equity ratio, which determines the business's degree of dependence on borrowed funds. By analyzing the total debt-to-book equity chart, an investor can see how the production costs of portable MRIs and regulatory barriers for Hyperfine, Inc. (HYPR) increase the debt load amid the slow adoption of the product.

Pesaing Hyperfine, Inc.

Utang-utang marang kapitalisasi buku ABT (Abbott Laboratories)|Utang-utang marang kapitalisasi buku thermofisher.com TMO|Utang-utang marang kapitalisasi buku GEHC|MTD: Utang marang aset resik|Rasio utang marang kapitalisasi buku Waters Corp.|TECH (Bio-Techne Inc.) - Rasio utang marang nilai buku|Rasio utang marang kapitalisasi buku BRKR (Bruker Corporation)|Utang-utang marang nilai buku AZTA|VREX (Varex Imaging Corporation) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Semler Scientific Inc SMLR|Utang marang nilai buku Butterfly iQ (BFLY)|Utang marang modal buku Mesa Laboratories Corp. MLAB|Utang-utang marang kapitalisasi buku QSI (Quantum-Si)|NNOX - Utang-utang marang aset resik|QTRX (Quanterix) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku 908 Devices Inc|CV - Utang marang nilai buku|Rasio utang marang aset resik MXCT|Rasio utang marang kapitalisasi buku RPID (Rapid Micro Biosystems)|Utang marang nilai buku seer.bio (SEER)|FONR: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Daxor Corp DXR|Spectral AI (MDAI) - Utang-utang marang kapitalisasi buku|VIVS - Rasio utang marang nilai buku|Aclarion - Utang-utang marang kapitalisasi buku|Akoya Biosciences, Inc. (AKYA) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku THMO|Utang marang nilai buku Talis Biomedical Corp|Utang-utang marang kapitalisasi buku TTOO